New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
Essential
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
FDA Watch: Natera, Valar Labs Receive FDA Clearances for Bladder Cancer Tests
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Already a member? Log in here
Upcoming G2 Events
...
Already a member? Log in here
News-At-A-Glance: CMS Proposes New Metropolitan Areas
...
Already a member? Log in here
News-At-A-Glance: Senior Medicare Patrol Report
...
Already a member? Log in here
News-At-A-Glance: CMS Releases New Data for Hospitals
...
Already a member? Log in here
Compliance Corner
...
Already a member? Log in here
LabMD vs. FTC Trial Delayed Amid Dramatic Twists and Turns
...
Already a member? Log in here
Should We Care About Millennium vs. Ameritox?
...
Already a member? Log in here
Lessons Learned From Calloway Laboratories Settlement
...
Already a member? Log in here